Please login to the form below
anxiety
This page shows the latest anxiety news and features for those working in and with pharma, biotech and healthcare.
Moderna looks to price COVID-19 vaccine at $50-$60 per course
If finalised, these new executive orders could force us to rethink those plans, consider job reductions and add to the economic and health anxiety already widely felt in our country,” he
Latest news
-
Low-dose LSD looks safe for Alzheimer’s patients, but will it work?
Earlier studies point to potential benefits for LSD in depression, anxiety, and substance abuse, and Eleusis’ hope is that low dose LSD may also have significant potential in treating Alzheimer’s,
-
Karuna’s shares spike on schizophrenia drug data
anxiety, that can seriously limit the clinical effectiveness of current antipsychotic drugs, most of which have been in use for decades.
-
Prescription drug dependence 'linked to deprivation', says PHE
This included benzodiazepines for anxiety and insomnia, z-drugs for insomnia, gapapentinoids for neuropathic pain, opioid pain medications for chronic non-cancer pain and antidepressants.
-
Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
Pear Therapeutics says the study also showed improvements in anxiety symptoms (as measured by the General Anxiety Disorder 7-item (GAD-7) scale), with a treatment arm mean of 3.16
-
Otsuka’s Alzheimer’s agitation drug hits the mark
antipsychotic drugs – which have been linked to a higher risk of death in dementia – as well as antidepressants and anxiety medications.
More from news
Approximately 1 fully matching, plus 149 partially matching documents found.
Latest Intelligence
-
Health trust in a COVID-19 world – a unique opportunity for pharma
a whole has become a more valuable commodity as uncertainty and anxiety around COVID-19 and its impact has become more prevalent.
-
New truths and realities in these strange times
Their reality, behind their ‘locked-down’ doors, is full of concern, risk and increased anxiety that will likely impact their physical and mental health. ... Many participants in the PoTSLIVE project mentioned increased anxiety, which is a concern as
-
Growing up as a patient is hard to manage
Not only do many patients experience anxiety as a result of an unfamiliar care team, undefined degree of control or unexpected changes to therapy, but they can also face system-level
-
Integrating patient reported outcomes into clinical trials
However, the HTA acknowledges the limitations of the index, noting that “the DLQI has limited validity in some people, and may miss anxiety and depression.”.
-
Changing healthcare communications
Replacing anxiety with confidence, mediocrity with purpose. By David Hunt and Lou Shipley. ... But only if we replace anxiety with confidence, mediocrity with purpose, and attract the brightest, smartest and most creative minds to join our cause.
More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.
Latest appointments
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
The Lucid Group Wellbeing Champions embark on their MHFA training
A mentally sound organisation is good for talent and business. Statistics from Mental Health First Aid (MHFA) England point out to mental health illness (such as depression or anxiety) accounting to
-
Medical Device Clinical Trials 2020
Adopting virtual reality as a tool for participant retention Amazingly, virtual reality (VR) has been shown to reduce pain, anxiety and stress.
-
Understanding COVID-19 and varying responses across the globe
There was also investment in providing the public with four face masks per household to only be used when a member presents with symptoms in an effort to reduce public anxiety.
-
When community can inspire a social media movement
anxiety can take on their rosacea and mental well-being, with hints and tips to manage this.
-
War on drugs: the use of controlled substances in medicine
Psilocybin (aka magic mushrooms) has shown promise in treating a variety of difficult-to-treat health conditions such as depression and cancer-related anxiety.
More from PMHub
Approximately 1 fully matching, plus 33 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Roche’s Ocrevus boasts positive long-term data in MS
- Gavi says 76 wealthy countries have committed to COVAX vaccine facility
- First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
Bedrock Group
Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
